Where will clog-free, clot-free, infection-resistant devices transform the patient experience?
For Neurosurgery Patients
We are reinventing care for pediatric and adult hydrocephalous where:
98% of the leading hydrocephalus shunts fail within 10 years.
40% of the leading hydrocephalus shunts fail within 1 year.
Current products featuring Cerulean Surfacetechnology:
Hydrocephalus shunt
Extraventricular drain
Cerulean technology “demonstrated increased survival time, improved clinical outcome scores, and significantly reduced total attached cells on the ventricular catheters compared with standard clinical control ventricular catheters.”